£7m invested in fight against antimicrobial resistance

Phico Therapeutics Ltd, a biotechnology company developing engineered phage technology as the basis of a new generation of antibiotics to overcome antibacterial resistance, has announced £7m in new investment. The financing was led by growth...

Light therapy helmet could help dementia patients

A new infrared light therapy has the potential to help people with dementia. A pilot study recently investigated how transcranial photobiomodulation therapy (PBM-T) –transferred through a specially adapted helmet -- could boost memory, motor function...

Lab-grown ‘mini-stomachs’ could shed light on children’s COVID symptoms

A ‘lab-grown model’ of the human stomach, that can be used to study how infections affect the gastrointestinal system, has been developed for the first time. A UCL-led team of international scientists have built on...

WEAPONISING THE FIGHT AGAINST ANTIBIOTIC RESISTANCE

Could faecal transplants be an effective weapon in the fight back against antibiotic resistance? A research team at Guy’s and St Thomas’ NHS Foundation Trust intends to find out, once and for all. By HELEN...

Stay future-ready: Running parallel operations with a CDMO during clinical trials

Bringing a drug candidate through clinical trials is a challenging and high-risk process, since only 10% of candidates actually reach final approval. Both established pharma companies and small startups are often faced with this...

Adult Vaccination

“Vaccination can provide cost-effective protection against a host of diseases throughout life, but remains an underused public-health strategy in adults for the promotion of healthy ageing. Without specific vaccination programmes for the adult population...

Shaping the science of oncology

Dr Fiona McLaughlin is the new Chief Scientific Officer of Avacta’s Therapeutics Division. She talks to Karen Southern about her mission to develop first and best-in-class cancer drugs. From the day that Dr McLaughlin –...

DMT-assisted therapy: changing the way we think about depressive disorders

A ‘spirit molecule’ from the Amazon could be a game changer in the treatment of major depressive disorders. Dr Carol Routledge, of Small Pharma, talks to Karen Southern about her pioneering work with DMT. Psychedelic...

CRYONISS EARNS COVETED MHRA QUALITY MARK

Experts in biological sample, and medicinal product, storage and logistics management, CRYONISS offers a comprehensive storage service from ambient down to vapour phase liquid nitrogen. The Cheshire-based team has a wealth of experience in supporting...

Pioneering technique paves way for fast and cheap fabrication of rapid medical diagnostic tools

Breakthrough promises to democratise microfluidics and lab-on-a-chip technology, benefiting resource-poor countries and settings. New technology developed by the University of Bristol has the potential to accelerate uptake and development of on-chip diagnostic techniques in parts...

Bringing patients and providers together one tweet at a time

As an open forum for human interaction, social media have become the great equalizer of health information – providing a means for patients and health care providers to connect outside of the hospital or...

Automated drug discovery platform brings about paradigm change for research

Bringing a single new drug to market takes years of research and costs billions – with the COVID-19 pandemic highlighting even more how critical it is to accelerate this process. The high costs and...

Relentlessly searching for the cure

Martina Slapkova - Research Information Co-ordinator at the Motor Neurone Disease Association Motor neuron disease (MND), also known as Amyotrophic Lateral Sclerosis across the globe, has been puzzling researchers and clinicians ever since it was...

How a Novel Drug Discovery Technology Could Help in the Fight Against COVID-19

By Dr Asif Tulah, Alcyomics Alcyomics has been adapting its service provision and assays to play their part in the race to find new treatments for COVID-19 (SARS-CoV-2) and to better understand how this virus works....

Personalised medicine: driving a need for greater diversity

Kate Shaw, CEO of Innovative Trials, investigates one of the biggest challenges facing clinical research today. Personalised medicines, particularly gene and cell therapies, offer new opportunities for treating serious conditions such as muscular dystrophy, cystic fibrosis...

Matching clinical trials with unmet clinical need

A new tool that helps target clinical trials to areas of unmet clinical need has sparked interest in both the National Health Service (NHS) and the commercial clinical research world. Stephen Lock, Head of...